Bird · Pyrrhura molinae · typical adult weight 0.06–0.08 kg
Meloxicam is dosed at 0.5–1 mg/kg i.m., p.o. q12-24h in green-cheeked conures, per b Cole GA, Paul-Murphy J, Krugner-Higby L et al. (2009) Analgesic effects of intramuscular administration of meloxicam in Hispaniolan parrots (Amazona ventralis) with experimentally induced arthritis. American Journal of Veterinary Research 70(12), 1471-1476 | c Lacasse C, Gamble KC and Boothe DM (2013) Pharmacokinetics of a single dose of intravenous and oral meloxicam in Red-tailed Hawks (Buteo jamaicensis) and Great Horned Owls (Bubo virginianus). Journal of Avian Medicine and Surgery 27(3), 204-210 — Source: BSAVA Small Animal Formulary, 10th Ed, Part B: Exotic Pets, p.209 doi:10.2460/ajvr.70.12.1471 — LOCATOR CONVENTION 2026-08-07: the bare 'p.209' in this citation is the PDF index of the held scan, not the printed page. The PRINTED page is p.195; verified by finding the drug named there. If you are holding the book, turn to p.195. — SOURCE EDITION: BSAVA Small Animal Formulary, Part B — Exotic Pets — ISBN 9781910443712, https://openlibrary.org/isbn/9781910443712. Meloxicam is used in green-cheeked conures for Inflammation and pain, acute and chronic musculoskeletal disorders, postoperative pain. Routes documented in green-cheeked conures: i.m., p.o.. A typical adult green-cheeked conure weighs 0.06–0.08 kg. ExoticRx lists 1 cited dose rule for Meloxicam in green-cheeked conures, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Metacam
| Route | Dose | Frequency | Indication | Evidence | Source |
|---|---|---|---|---|---|
| i.m., p.o. | 0.5–1 mg/kg | q12-24h | Inflammation and pain, acute and chronic musculoskeletal disorders, postoperative pain | Moderate | b Cole GA, Paul-Murphy J, Krugner-Higby L et al. (2009) Analgesic effects of intramuscular administration of meloxicam in Hispaniolan parrots (Amazona ventralis) with experimentally induced arthritis. American Journal of Veterinary Research 70(12), 1471-1476 | c Lacasse C, Gamble KC and Boothe DM (2013) Pharmacokinetics of a single dose of intravenous and oral meloxicam in Red-tailed Hawks (Buteo jamaicensis) and Great Horned Owls (Bubo virginianus). Journal of Avian Medicine and Surgery 27(3), 204-210 — Source: BSAVA Small Animal Formulary, 10th Ed, Part B: Exotic Pets, p.209 doi:10.2460/ajvr.70.12.1471 — LOCATOR CONVENTION 2026-08-07: the bare 'p.209' in this citation is the PDF index of the held scan, not the printed page. The PRINTED page is p.195; verified by finding the drug named there. If you are holding the book, turn to p.195. — SOURCE EDITION: BSAVA Small Animal Formulary, Part B — Exotic Pets — ISBN 9781910443712, https://openlibrary.org/isbn/9781910443712 |
Every held source for this drug and species, as printed. Where they differ, both are shown — the choice is yours, not ours.
The sources disagree for this combination. The ranges below do not overlap on a comparable route. This is not an error in one of them — published veterinary references differ, and reconciling them for a particular patient is a clinical judgement.
| Dose (mg/kg) | Route | Source | As printed |
|---|---|---|---|
| 0.1 | PO | BSAVA Manual of Psittacine Birds, 2nd edp.103 | 0.1 mg/kg orally q24h be used successfully t o maintain t h e avian patient during inhalation anaesthesia. To prevent volotrauma | |
| 0.5–1 | IM | BSAVA Small Animal Formulary, 10th ed — Part B (Exotic Pets)p.209 | 0.5-1.0 mg/kg i.m., p.o. q12-24h b,c. NB: doses of up to 20 mg/kg p.o. did not result in nephrotoxicity |
| 20 | PO | BSAVA Small Animal Formulary, 10th ed — Part B (Exotic Pets)p.209 | 0.5-1.0 mg/kg i.m., p.o. q12-24h b,c. NB: doses of up to 20 mg/kg p.o. did not result in nephrotoxicity in American kestrels, but therapeutic and toxicolog |
Need the exact dose for your patient?
These ranges are per kg. Enter your green-cheeked conure's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Preferential COX-2 inhibitor, reducing prostaglandin synthesis. Provides anti-inflammatory, analgesic, and antipyretic effects.
Use with extreme caution in cats. Jurisdiction-specific labeling: the US (FDA) label authorizes a single SC dose only, with a boxed warning against repeated use; EU/UK/AU labels authorize repeated oral dosing for chronic musculoskeletal pain — follow your jurisdiction's label. GI ulceration risk. Avoid in dehydrated, hypovolemic, or renally compromised patients. Do not combine with other NSAIDs or corticosteroids.
Species-specific contraindications and adverse-reaction reports for green-cheeked conures may differ from canine / feline reference data — consult the primary citations listed with each rule.
Meloxicam dose range in green-cheeked conures, with cited source references: i.m., p.o. 0.5–1 mg/kg q12-24h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Meloxicam in green-cheeked conures: i.m., p.o..
Meloxicam is indicated in green-cheeked conures for: Inflammation and pain, acute and chronic musculoskeletal disorders, postoperative pain.
These are general warnings for Meloxicam across species; consult the green-cheeked conure dosing table above for species-specific guidance. Use with extreme caution in cats. Jurisdiction-specific labeling: the US (FDA) label authorizes a single SC dose only, with a boxed warning against repeated use; EU/UK/AU labels authorize repeated oral dosing for chronic musculoskeletal pain — follow your jurisdiction's label. GI ulceration risk. Avoid in dehydrated, hypovolemic, or renally compromised patients. Do not combine with other NSAIDs or corticosteroids.
Why a species-specific page? Meloxicam pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in green-cheeked conures — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.
| 1 | PO | Carpenter's Exotic Animal Formulary, 6th edTable 5.6 | 0.5-1 mg/kg PO q12h 0.5 mg/kg IM q24h - Afr 1 mg/kg PO q48h |
| 0.5–3 | PO | Carpenter's Exotic Animal Formulary, 6th edTable 5.6 | 0.5-3 mg/kg PO q8- 12h,538 |
| 0.5 | PO | Carpenter's Exotic Animal Formulary, 6th edTable 5.6 | 0.5 mg/kg PO, IM q8-12h1017 |
| 20 | PO | Carpenter's Exotic Animal Formulary, 6th edTable 5.6 | 2, 10, 20 mg/kg PO q12h × 7 days 5 mg/kg Red transdermally com |
| 5 | PO | Carpenter's Exotic Animal Formulary, 6th edTable 5.6 | 2, 10, 20 mg/kg PO q12h × 7 days 5 mg/kg Red transdermally com |
| 2 | PO | Carpenter's Exotic Animal Formulary, 6th edTable 5.6 | 2 mg/kg PO, IM |
| 0.5–1 | PO | Carpenter's Exotic Animal Formulary, 6th edTable 5.6 | 0.5-1 mg/kg PO q12h 0.5 mg/kg IM q24h - Afr 1 mg/kg PO q48h |
| 0.5 | IM | Carpenter's Exotic Animal Formulary, 6th edTable 5.6 | 0.5-1 mg/kg PO q12h 0.5 mg/kg IM q24h - Afr 1 mg/kg PO q48h |
Figures are transcribed from the cited page or table of each held edition and are shown for reference only. They are not dose recommendations, they do not feed the calculator, and none has been reviewed by a veterinarian.